Archives

In recent years, artificial intelligence (AI) has rapidly become a cornerstone of innovation in life sciences. But while headlines often focus on its use in radiology or drug discovery, a quieter revolution is taking place in microbiology — one that may prove just as transformative, particularly for preclinical research in infectious diseases.